CMS Bound To Current Approach To Sequester Cuts For Part B Drugs, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS says it must follow its current approach to Part B drug payment cuts, but oncology provider groups maintain the administration does have discretion to exempt at least part of the ASP plus 6% payment from the required 2% reduction under the sequester.